Robert Carey
CIK 1602064 · EVP, Chief Business Officer · last filed 2025-11-07
Robert Carey is an EVP, Chief Business Officer who has filed 71 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for XAIR, was dated Nov 7, 2025. Across all open-market trades the lifetime net is +$8.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.06M
4
71
$8.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XAIR | Director | 5,543,490 | $0.37 | $2.06M | $9.42M | 36 | 2025-11-07 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 11 | 2025-06-16 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, Chief Business Officer | 266,358 | $116.30 | $30.98M | -$509.8K | 17 | 2019-03-25 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 8,206 | — | — | $0 | 6 | 2017-01-20 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-07 | XAIR | Mixed | — | $0 | EDGAR |
| 2025-11-07 | XAIR | Mixed | — | $0 | EDGAR |
| 2025-06-16 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2025-03-28 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2025-03-17 | XAIR | Buy (P) | +1,000,000 | $250.1K | EDGAR |
| 2024-11-26 | XAIR | Mixed | — | $0 | EDGAR |
| 2024-10-01 | XAIR | Mixed | +1,476,626 | $744.7K | EDGAR |
| 2024-08-15 | XAIR | Buy (P) | +100,000 | $39.7K | EDGAR |
| 2024-06-06 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-03-21 | XAIR | Grant (A) | +602,410 | $1.00M | EDGAR |